BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30303958)

  • 1. Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.
    Pan Q; Law COK; Yung MMH; Han KC; Pon YL; Lau TCK
    PLoS One; 2018; 13(10):e0198980. PubMed ID: 30303958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA aptamers selection for carcinoembryonic antigen (CEA).
    Izabella Abreu de Melo M; Rodrigues Correa C; da Silva Cunha P; Miranda de Góes A; Assis Gomes D; Silva Ribeiro de Andrade A
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127278. PubMed ID: 32527457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
    Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
    J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer.
    Hamazoe R; Maeta M; Matsui T; Shibata S; Shiota S; Kaibara N
    Eur J Cancer; 1992; 28A(8-9):1351-4. PubMed ID: 1515249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA72-4: a new tumour marker for gastric cancer.
    Byrne DJ; Browning MC; Cuschieri A
    Br J Surg; 1990 Sep; 77(9):1010-3. PubMed ID: 2207563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.
    Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW
    Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer].
    Koizumi F; Odagiri H; Fujimoto H; Kawamura T; Ishimori A
    Rinsho Byori; 1992 May; 40(5):523-8. PubMed ID: 1507478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
    Yin LK; Sun XQ; Mou DZ
    Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-based single-stranded DNA aptamer specifically targets gastric cancer.
    Zhang X; Zhang J; Ma Y; Pei X; Liu Q; Lu B; Jin L; Wang J; Liu J
    Int J Biochem Cell Biol; 2014 Jan; 46():1-8. PubMed ID: 24501772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers.
    Liu HN; Yao C; Wang XF; Zhang NP; Chen YJ; Pan D; Zhao GP; Shen XZ; Wu H; Liu TT
    World J Gastroenterol; 2023 Jan; 29(4):706-730. PubMed ID: 36742169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells.
    Graham JC; Zarbl H
    PLoS One; 2012; 7(4):e36103. PubMed ID: 22536456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
    Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
    J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma.
    Lucarotti ME; Habib NA; Kelly SB; Rothnie ND; Nelson O; Lindholm L; Cooper MJ; Wood CB; Williamson RC
    Eur J Surg Oncol; 1991 Feb; 17(1):51-3. PubMed ID: 1995358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.